Marksans Pharma Limited (MARKSANS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Marksans Pharma Limited (NSE: MARKSANS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹318.00, P/E 25.8, ROE 15.2%.
Get the AI verdict on MARKSANS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
MARKSANS chart with trendlines
Is MARKSANS a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Marksans Pharma Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
MARKSANS key facts
| Price and valuation | |
|---|---|
| Share price | ₹318.00 |
| Market cap | ₹14,435 Cr |
| P/E ratio | 25.8 |
| P/B ratio | 4.33 |
| EPS | ₹12.36 |
| Book value per share | ₹73.50 |
| Dividend yield | 0.28% |
| 52-week range | |
| 52-week high | ₹350.95 |
| 52-week low | ₹155.00 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 43.87% |
| FIIs | 19.06% |
| DIIs | 5.54% |
| Public | 31.53% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.